Spotlight on
21012 items found
Oncology
Treating primary bone cancer: The potential of listeria-based bioengineered bacterial immunotherapy
Osteosarcoma is an extremely challenging and often aggressive cancer …
News
US lawmakers seek ban on DTC advertising
US Senators Bernie Sanders and Angus King have introduced a bill that …
News
AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance
AstraZeneca has forged a wide-ranging collaboration with Chinese …
Patients
Breathing through barriers: Lived experience, innovation, and the future of Alpha-1 care
When a disease runs in your family, you don’t learn about it from …
News
Moderna's RSV shot gets US nod for use in younger adults
The label for Moderna's respiratory syncytial virus (RSV) vaccine …
Oncology
Beyond traditional cancer treatment: Can we confront unmet needs in oncology with a fourth revolution?
Surgery, chemotherapy, radiotherapy, and immunotherapy are designed …
News
Pushback rises against RFK Jr's new ACIP membership
Medical organisations have criticised Robert F Kennedy Jr's newly …
Market Access
Partner Content
EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships
EVERSANA, a leading provider of global commercial services to the …
News
NHS starts first national rollout of Blenrep for myeloma
England is the first country in the world to make GSK's anti-BCMA …
News
Data at EULAR back Biogen, UCB's first-in-class lupus drug
Full results from the first phase 3 trial of UCB and Biogen's …
Oncology
ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bladder cancer treatment
At ASCO 2025, ImmunityBio’s chief medical officer, Dr Sandeep Reddy, …
Oncology
Treating primary bone cancer: The potential of listeria-base...
In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
